Atlas Trials

Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy

Clinical trial NCT04138628 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04138628
Sponsor
Jørgen Bjerggaard Jensen
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder CancerBladder Cancer, Metastatic
Start date
2020-03-24
Primary completion
2024-08-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.